Press

Biotechnology and Regenerative Agriculture: The alliance for the future of farming

09/09/2025

Climate change · Agrifood · Food & feed · Agriculture

• Regenerative Agriculture aims to restore agricultural ecosystems through healthier soils, resilient crops, and systems that capture carbon, generate income, and address the challenges of climate change.
• Bayer promotes regenerative agriculture through practices that improve soil health, more resilient hybrid and oilseed crops, and biotechnology with NGT, complemented by digitalization, circular economy initiatives, and collaboration with farmers to enhance productivity and sustainability.

AseBio

The european bioeconomy urges the EC to harmonize policies, strengthen funding, and create more favorable markets for innovation

01/09/2025

Bioeconomy · Circular economy

• The European project ShapingBio, of which AseBio is a partner, has presented a report with key recommendations for the upcoming EU Bioeconomy Strategy, aimed at driving a more sustainable, circular, and competitive economy.
• The recommendations are based on broad engagement with nearly 2,000 key bioeconomy stakeholders, including policymakers, industry leaders, researchers, and civil society representatives.
• These recommendations have been well received by the European Commission and could strengthen Europe’s resilience, competitiveness, and sustainability within the framework of its new Bioeconomy Strategy.

AseBio

86 AseBio members working on new solutions to tackle the challenges of the Green Transition

16/07/2025

Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy · Circular economy

• The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the planet’s balance.
• 33% of these solutions target areas such as animal health and nutrition, food safety, functional foods, fermentation or biocatalysis, and substance detection.
• Biotechnology in the green transition continues to face barriers at many levels. According to the findings, several factors currently hinder the shift toward a more sustainable system.

AseBio

Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show promising results

13/07/2025

Healthcare

• The World Health Organization recognizes over 150 different types of sarcomas, a rare disease that poses significant diagnostic and therapeutic challenges.
• The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric sarcomas, with a special focus on Ewing sarcoma.
• Collaboration among clinical centers, academic groups, and biotech companies is essential to accelerate research and overcome the challenges posed by rare diseases

AseBio

AseBio presents its proposals to the European Commission for the future Biotech Act

23/06/2025

Healthcare · Agrifood · Industrial biotechnology

• We warmly welcome this initiative, convinced that a solid legislative framework is essential to unlocking the full potential of biotechnology for the benefit of the economy, society, and Europe’s strategic autonomy.
• Our contribution addresses the sector’s main challenges with proposals focused on three pillars: agile funding for innovation, simpler and faster regulation, and a more cohesive and globally competitive EU.
• These proposals are aligned with the consensus of the European industry and reflect our strong commitment to building a resilient and world-leading biotechnology ecosystem.

AseBio

R&D investment in the biotech sector grows by 5.2% to 1,282 million euros

11/06/2025

Healthcare · Agrifood · Industrial biotechnology · Financing · Talento

• In 2023, the activity of biotech companies in Spain generated more than 13,000 million euros of income, which represents 1.1% of the national GDP.
• After an exceptional 2023 for the sector in terms of attracting investment, in 2024 it raised a total of 181 million euros in 53 operations.
• The number of biotech companies in Spain grew in 2024 to 1,014 companies, an increase of 4.1% over the previous year.
• Once again this year, biotech companies maintain the second position in the ranking of sectors with the highest percentage of researchers over total employees with 15.99%.

AseBio

World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move towards increasingly precise and timely treatments”

30/05/2025

Healthcare · Personalized medicine · Advanced therapies

• Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple sclerosis is understood and treated.
• Each year, more than 2,500 new cases of multiple sclerosis (MS) are diagnosed in Spain, and as of 2024, over 55,000 people were living with this autoimmune disease.
• “Biotechnological development will allow us to adapt treatment to the unique characteristics of each person and detect signs of progression even before they become clinically evident.”

AseBio

AseBio strengthens the strategic role of the biotechnology sector in the National Forum for Emerging Companies

29/05/2025

Industrial biotechnology · Financing

• This space, created at the end of last year by the Government, is intended as a space for dialogue and collaboration between the public sector and the Spanish entrepreneurial ecosystem, driven by the "Startups Law."
• AseBio stands as the only sectoral organization represented in this body, alongside the digital sector, highlighting the recognition of biotechnology as a strategic sector within the field of emerging companies.
• The "Startups Law," enacted in 2022, incorporated proposals from AseBio, such as extending the period for considering biotech companies as startups from five to seven years, and expanding the tax deduction base for investments in newly created companies.

AseBio

The essential role of biotechnology in the production of safe, nutritious, and sustainable food

28/05/2025

Climate change · Agrifood · Food & feed · Agriculture

• Over 800 million people suffer from chronic hunger, and biotechnology is revolutionizing the way we produce food, offering more sustainable and efficient alternatives.
• In the face of hunger challenges, biotechnological innovation opens new opportunities: insect-based proteins, more resilient crops, predictive biostimulants, and digital solutions for more precise and regenerative agriculture.
• AseBio partners are leading the shift towards a more sustainable agri-food system, combining biotechnology, artificial intelligence, and regenerative practices to ensure safe and affordable food for all.

AseBio